DLH Holdings Corp. (DLHC) - 10-K Summary
Business Context and Reporting Period
Company: DLH Holdings Corp.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended September 30, 2024
Business Overview: DLH provides health, readiness, and digital transformation solutions to U.S. federal government agencies. The company operates primarily as a prime contractor, delivering services in digital transformation/cybersecurity, science research and development, and systems engineering. Approximately 98% of revenue is derived from federal government contracts.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2024 | Fiscal 2023 |
|---|---|---|
| Revenue | $395,937 | $375,872 |
| Net Income | $7,397 | $1,461 |
| Operating Income | $24,900 | $17,091 |
| Operating Margin | 6.3% | 4.5% |
| Net Cash from Operating Activities | $27,366 | $31,033 |
| Total Debt Obligations (Principal) | $154,558 | $179,359 |
| Cash and Cash Equivalents | $342 | $215 |
| Backlog (Total) | $690.3 million | $704.8 million |
| Funded Backlog | $155.1 million | $169.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased by $20.1 million (5.3%) to $395.9 million, primarily driven by the December 2022 acquisition of DLH, LLC (formerly Grove Resource Solutions).
- Profitability Improvement: Net income surged to $7.4 million from $1.5 million. This improvement was significantly aided by the absence of a $7.7 million impairment loss on long-lived assets and $1.7 million in corporate development costs that were incurred in fiscal 2023.
- Debt Reduction: The company made voluntary prepayments of $19.0 million on its secured term loan during fiscal 2024, reducing the principal balance from $169.8 million to $142.5 million.
- Customer Concentration: Revenue from the Department of Health and Human Services (HHS) increased to 46.6% of total revenue, while the Department of Veterans Affairs (VA) share decreased slightly to 35.3%.
Outlook, Risks, and Management Commentary
- Government Funding: The U.S. government is operating under a Continuing Resolution (CR) expiring December 20, 2024. Management anticipates potential delays in new program starts or contract awards if appropriations are not timely enacted, though key programs historically receive bipartisan support.
- VA Contract Recompete: A significant portion of revenue ($139.9 million) comes from the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program. The VA is currently re-competing these contracts with a set-aside for Service-Disabled Veteran Owned Small Businesses (SDVOSB). DLH lost one location to an unaffiliated SDVOSB but continues to operate as the prime contractor for seven locations while the process concludes.
- Liquidity: The company maintains a secured revolving line of credit with $18.1 million in unused capacity. Management believes cash flow from operations is sufficient to support operations for the next 12 months.
- Risks: Key risks include dependence on federal appropriations, potential loss of major contracts due to SDVOSB set-asides, cybersecurity threats, and the impact of inflation on fixed-price contracts.
Investor Verification Checklist
- VA CMOP Recompete Status: Verify the outcome of the VA's solicitation for the remaining seven CMOP locations and DLH's ability to retain prime or subcontractor roles.
- Debt Covenant Compliance: Confirm continued compliance with the minimum fixed charge coverage ratio (1.25:1.00) and total leverage ratio (max 4.50:1.00) under the credit agreement.
- Backlog Conversion: Monitor the conversion rate of the $690.3 million backlog into revenue, noting that only $155.1 million is currently funded.
- Government Shutdown Impact: Assess the potential financial impact if the Continuing Resolution expires without a new budget, potentially causing a government shutdown.
- Non-GAAP Adjustments: Review the reconciliation of Adjusted EBITDA, noting the exclusion of one-time impairment and acquisition costs from the prior year to understand core operational performance.